Company intelligence / Profile preview

Adva-tec

Anderson, South Carolina, United States

Ownership: Public · ADV
Development stage: Other

Overview

No clinical results or product pipeline information is publicly available for Adva-tec, Inc. The company is classified under pharmaceutical and medicine manufacturing but does not disclose specific products or clinical programs[2].

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Financials

Market cap: $410.6M
Total revenue: $889.5M
Enterprise value: $1.8B

Beyond the preview

Go deeper on Adva-tec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adva-tec.

Explore the full profile